Moussie Haile Co-founded Apex Infusion Announces Partnership with SkyKnight Capital

Apex's management team will continue to lead the business, and keep a significant ownership stake. FFL Partners will also remain a minority investor. The deal is expected to close after receiving the required regulatory approvals.

Apex was built to provide high-quality infusion care, improve patient access, and reduce healthcare costs. Today, the company serves patients through a large network of home infusion nurses and around 40 ambulatory infusion centres.

Read More:California-Based Prosper Medical Scores $16M in Funding Round

With support from SkyKnight Capital, Apex plans to explore expansion into new markets, build partnerships with health systems, and insurance providers and invest in technology to improve patient access and care.

Moussie Haile, PharmD, CEO and co-founder of Apex, said, "What our team has built at Apex is something special – a best-in-class infusion platform designed to optimize the patient experience at every step. By delivering therapy in a comfortable clinical setting or the familiarity of home, we give patients better outcomes, greater dignity, and a real improvement in their quality of life.

“Apex has reached an exciting milestone. We have built a differentiated platform, established strong relationships across the healthcare ecosystem, and proven that our model can scale rapidly. With SkyKnight and FFL, we are well positioned to accelerate our expansion and extend Apex’s model of care to more patients nationwide,” said Rick Smith, Executive Chairman, and co-founder of Apex.

“We have enjoyed our partnership with the talented Apex team and truly respect their deep commitment to their patients,” said Karen Winterhof, Partner at FFL Partners. “Apex has become a market leader within infusion treatment therapy, and the Company is well positioned to continue delivering high quality patient care.”

"We are excited to partner with Rick, Moussie and FFL to continue building Apex into the alternate site infusion partner of choice for patients, providers and payors," said Don Wu, Managing Director at SkyKnight Capital. "Our investment approach is guided by a firm belief that industry leaders are built by exceptional management teams delivering uncommon value to their customers, employees, and society.

About Apex Infusion

Founded in 2006 by Moussie Haile, Apex Infusion is an infusion care company that provides treatment through ambulatory infusion centres and in-home care services. The company focuses on expanding access to infusion therapy while delivering high-quality care and better outcomes for patients, healthcare providers, and insurance partners.

Read More:Stephen Haney Co-founded Paper Scores $34M in Series A Funding